Chronic Liver Disease Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Chronic Liver Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

LSM and SSM for the Diagnosis of CSPH: a Prospective Cohort Study

Advanced Chronic Liver Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre200 enrolled1 locationNCT06181409
Recruiting
Not Applicable

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

Liver CancerHepatocellular CarcinomaCirrhosis+1 more
Assistance Publique - Hôpitaux de Paris944 enrolled1 locationNCT05095714
Recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

Liver CancerNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis+4 more
Institut National de la Santé Et de la Recherche Médicale, France800 enrolled1 locationNCT04690972
Recruiting

3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

Cirrhosis, LiverAdvanced Chronic Liver DiseasePortal Hypertension
Shengjing Hospital150 enrolled1 locationNCT05475015
Recruiting

Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

Hepatocellular CarcinomaHepatocarcinomaLiver Diseases+1 more
University Hospital Muenster600 enrolled1 locationNCT06523608
Recruiting

Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

Hepatocellular CarcinomaCirrhosisCirrhosis Due to Hepatitis B+3 more
University of Oxford300 enrolled2 locationsNCT06658782
Recruiting

hepatomiR cACLD Study

Portal HypertensionChronic Liver Disease and CirrhosisChronic Liver Disease
Karl Landsteiner University of Health Sciences156 enrolled1 locationNCT06432582
Recruiting
Not Applicable

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

CirrhosisPortal HypertensionChronic Liver Disease (CLD)
Fundacio Privada Mon Clinic Barcelona20 enrolled1 locationNCT06863012
Recruiting
Phase 4

Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease

Advanced Chronic Liver DiseasePortal HypertensionHepatic Decompensation
Chinese University of Hong Kong474 enrolled1 locationNCT06449339
Recruiting
Phase 3

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Hepatocellular CarcinomaAdvanced Chronic Liver DiseasePortal Hypertension
Hospital Universitari Vall d'Hebron Research Institute300 enrolled1 locationNCT06434753
Recruiting

Nottingham Community Liver Biomarkers Cohort

ObesityType 2 DiabetesAlcohol Use Disorder+2 more
University of Nottingham2,000 enrolled1 locationNCT02037867